These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24332861)

  • 1. Basal platelet-activating factor acetylhydrolase: prognostic marker of severe Hymenoptera venom anaphylaxis.
    Pravettoni V; Piantanida M; Primavesi L; Forti S; Pastorello EA
    J Allergy Clin Immunol; 2014 Apr; 133(4):1218-20. PubMed ID: 24332861
    [No Abstract]   [Full Text] [Related]  

  • 2. Basal Tryptase Levels Can Predict Clinical Severity in Hymenoptera Venom Anaphylaxis and Ischemic Cardiovascular Disorders.
    Farioli L; Losappio LM; Schroeder JW; Preziosi D; Scibilia J; Caron L; Nichelatti M; Pastorello EA
    J Investig Allergol Clin Immunol; 2019 Apr; 29(2):162-164. PubMed ID: 31017123
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated baseline mast cell tryptase: a marker of severe insect venom anaphylaxis.
    Heine RG; Freeman T
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):309-11. PubMed ID: 20610977
    [No Abstract]   [Full Text] [Related]  

  • 4. Hymenoptera Allergy and Mast Cell Activation Syndromes.
    Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
    Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of Hymenoptera venom allergy.
    Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
    Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of severe anaphylaxis for patients with Hymenoptera venom allergy: Are angiotensin-receptor blockers comparable to angiotensin-converting enzyme inhibitors?
    Caviglia AG; Passalacqua G; Senna G
    J Allergy Clin Immunol; 2010 May; 125(5):1171; author reply 1171-2. PubMed ID: 20347124
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy?
    Bilò MB; Corsi A; Martini M; Danieli MG; Alia S; Di Paolo A; Moroncini G; Vignini A
    Allergy; 2022 Mar; 77(3):1032-1035. PubMed ID: 34716604
    [No Abstract]   [Full Text] [Related]  

  • 8. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
    Stritzke AI; Eng PA
    Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hymenoptera venom immunotherapy.
    Bilò BM; Bonifazi F
    Immunotherapy; 2011 Feb; 3(2):229-46. PubMed ID: 21322761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hymenopteran venom allergy in 1994].
    Allerg Immunol (Paris); 1994 Nov; 26(9):327-8, 331-4. PubMed ID: 7865117
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of occupational Hymenoptera allergy.
    Ruëff F; Chatelain R; Przybilla B
    Curr Opin Allergy Clin Immunol; 2011 Apr; 11(2):69-74. PubMed ID: 21368617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine genes show distinct polymorphism pattern in Hymenoptera venom allergy.
    Sin BA; Tutkak H; Birben E; Köse K; Mısırlıgil Z
    Allergy; 2019 May; 74(5):1020-1022. PubMed ID: 30592056
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of Hymenoptera venom-allergic patients with negative specific IgE to venom extract by using recombinant allergens.
    Cifuentes L; Vosseler S; Blank S; Seismann H; Pennino D; Darsow U; Bredehorst R; Ring J; Mempel M; Spillner E; Ollert MW
    J Allergy Clin Immunol; 2014 Mar; 133(3):909-10. PubMed ID: 24290287
    [No Abstract]   [Full Text] [Related]  

  • 14. Mastocytosis and insect venom allergy.
    Bonadonna P; Zanotti R; Müller U
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a short pretreatment with omalizumab in children with anaphylaxis to hymenoptera venom immunotherapy: A report of three cases.
    Droitcourt C; Ponvert C; Dupuy A; Scheinmann P; Abou-Taam R; de Blic J; Lezmi G
    Allergol Int; 2019 Apr; 68(2):268-269. PubMed ID: 30342888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Allergy to Hymenoptera venom (author's transl)].
    Bousquet J; Menardo JL; Allouche J; Michel FB
    Nouv Presse Med; 1982 Jul 10-17; 11(32):2405-10. PubMed ID: 7111007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly.
    Guenova E; Volz T; Eichner M; Hoetzenecker W; Caroli U; Griesinger G; Burow G; Mitev V; Biedermann T
    Allergy; 2010 Jul; 65(7):919-23. PubMed ID: 20121769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
    González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
    Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant allergens rarely allow identification of Hymenoptera venom-allergic patients with negative specific IgE to whole venom preparations.
    Rafei-Shamsabadi D; Müller S; Pfützner W; Spillner E; Ruëff F; Jakob T
    J Allergy Clin Immunol; 2014 Aug; 134(2):493-4. PubMed ID: 25087228
    [No Abstract]   [Full Text] [Related]  

  • 20. Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis.
    van Anrooij B; van der Veer E; de Monchy JG; van der Heide S; Kluin-Nelemans JC; van Voorst Vader PC; van Doormaal JJ; Oude Elberink JN
    J Allergy Clin Immunol; 2013 Jul; 132(1):125-30. PubMed ID: 23498593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.